Literature DB >> 19276349

Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity.

Su Jung Song1, Min Sup Song, Soon Jung Kim, So Yeon Kim, Seung Hae Kwon, Jhin Gook Kim, Diego F Calvisi, Dongmin Kang, Dae-Sik Lim.   

Abstract

The Aurora (Ipl) kinase family plays important roles in the regulation of mitosis and tumorigenesis. The tumor suppressor RASSF1A controls mitotic progression by regulating anaphase-promoting complex (APC)-Cdc20 activity and microtubule stability, but the mechanism by which this action is regulated has not been previously established. Here, we show that Aurora A and B associate with and phosphorylate RASSF1A on serine 203 in vivo at different times and in different subcellular compartments during mitosis. Notably, both depletion of Aurora A by RNA interference and expression of a nonphosphorylatable RASSF1A (S203A) mutant gene led to a marked delay in prometaphase progression. This is likely because of the failure of RASSF1A to dissociate from Cdc20, constitutive inhibition of APC-Cdc20, and accumulation of mitotic cyclins. In contrast, the delay in prometaphase progression caused by Aurora A depletion was largely normalized by phosphomimetic RASSF1A (S203D). Finally, RASSF1A phosphorylation on serine 203 was up-regulated in Aurora A-overexpressing human tumors. These findings indicate that Aurora A plays a critical role in RASSF1A-APC-Cdc20 regulatory mechanisms that control normal prometaphase progression and that are involved in tumorigenesis. [Cancer Res 2009;69(6):2314-23.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276349     DOI: 10.1158/0008-5472.CAN-08-3984

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.

Authors:  Christine Bee; Anna Moshnikova; Christopher D Mellor; Justin E Molloy; Yulia Koryakina; Benjamin Stieglitz; Andrei Khokhlatchev; Christian Herrmann
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

2.  Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.

Authors:  Norman L Lehman; James P O'Donnell; Lisa J Whiteley; Robert T Stapp; Trang D Lehman; Kathleen M Roszka; Lonni R Schultz; Caitlin J Williams; Tom Mikkelsen; Stephen L Brown; Jeffrey A Ecsedy; Laila M Poisson
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

3.  Spatial Compartmentalization Specializes the Function of Aurora A and Aurora B.

Authors:  Si Li; Zhaoxuan Deng; Jingyan Fu; Caiyue Xu; Guangwei Xin; Zhige Wu; Jia Luo; Gang Wang; Shuli Zhang; Boyan Zhang; Fangdong Zou; Qing Jiang; Chuanmao Zhang
Journal:  J Biol Chem       Date:  2015-05-18       Impact factor: 5.157

4.  A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.

Authors:  Karen S Yee; Lukasz Grochola; Garth Hamilton; Anna Grawenda; Elisabeth E Bond; Helge Taubert; Peter Wurl; Gareth L Bond; Eric O'Neill
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

Review 5.  Tumor suppressor C-RASSF proteins.

Authors:  Hiroaki Iwasa; Shakhawoat Hossain; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2018-01-20       Impact factor: 9.261

6.  The Saccharomyces cerevisiae anaphase-promoting complex interacts with multiple histone-modifying enzymes to regulate cell cycle progression.

Authors:  Emma L Turner; Mackenzie E Malo; Marnie G Pisclevich; Megan D Dash; Gerald F Davies; Terra G Arnason; Troy A A Harkness
Journal:  Eukaryot Cell       Date:  2010-08-13

Review 7.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

Review 8.  Cdc20: a potential novel therapeutic target for cancer treatment.

Authors:  Zhiwei Wang; Lixin Wan; Jiateng Zhong; Hiroyuki Inuzuka; Pengda Liu; Fazlul H Sarkar; Wenyi Wei
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

10.  RASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.

Authors:  Ying-Ying Liang; Li-Sheng Zheng; Yuan-Zhong Wu; Li-Xia Peng; Yun Cao; Xue Cao; Ping Xie; Bi-Jun Huang; Chao-Nan Qian
Journal:  Cell Cycle       Date:  2014-03-10       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.